We are live on ! Find out more

Philip Morris

PM

Market cap $284B

182.53 USD

-3.64

1.96%

At close Updated Sep 4, 4:00 PM EDT

Pre-market

After hours

182.53

0.00

0%

1 day

-1.96%

5 days

-4.32%

1 month

-2.34%

3 months

4.31%

6 months

1.95%

Year to date

13.87%

1 year

13.27%

5 years

72.1%

10 years

78.32%

About: Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.

Employees: 84,900

Consumer Staples Tobacco

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 48.1%

Neutral 40.7%

Negative 11.1%

Philip Morris: The U.S. May Be The Next Growth Leg (Rating Downgrade)

Philip Morris International is downgraded to Hold as valuation reaches the high end of its historical range. PM's growth is driven by smoke-free products, now 42% of net revenue, with strong execution in international markets. U.S. expansion, especially with IQOS and ZYN, remains a key growth catalyst, but regulatory risks and competitive pressures persist.

Philip Morris: The U.S. May Be The Next Growth Leg (Rating Downgrade)

PMI U.S. Launches ZYN "When It Clicks," a New Brand Platform Built Around the Moment Everything Falls Into Place

The campaign centers on the "click" as a signature brand cue, rolling out across digital, out-of-home, and live cultural moments in 2026 STAMFORD, Conn., Sept. 3, 2026 /PRNewswire/ -- Philip Morris International's U.S. businesses (PMI U.S.) today announced the national rollout of "When It Clicks," ZYN's new brand campaign inspired by the universal moment when effort, timing, and confidence align.

The Motley Fool

I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.

It successfully pivoted from declining cigarettes toward higher-growth, higher-margin smoke-free products. Strong second quarter results show that this transformation is turning into solid financial performance.

I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.

Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of a fireside chat session with Jacek Olczak, Group CEO PMI, at the 2026 Barclays Global Consumer Conference on Tuesday, September 8, 2026, at approximately 9:45 a.m. ET. The webcast can be accessed here. An archived copy of the webcast will be available for six months post-event on the same page. The webcast can also be accessed on mobile devices by downloading PMI's IR Ap.

Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference

Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets - Premium Price Tag

PM's premium positioning across IQOS (heated), ZYN (nicotine pouches), VEEV One (vape), and Marlboro (cigarettes) underscores their robust pricing power amid uncertain macros. The smoke-free segment, led by ZYN and IQOS, now comprises >41% of revenues, supporting a multi-year asset renewal/adoption runway amid secular combustible decline. Premium valuations are justified by strong FCF, rich dividend growth, and lower debt leverage, with PM likely to announce the next payout hike in September.

Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets - Premium Price Tag

Zacks Investment Research

Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push

PM's FDA authorization for 11 ZYN ULTRA nicotine pouches expands its U.S. smoke-free portfolio and supports the long-term transformation.

Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push

Altria, Philip Morris International sign contract manufacturing deals

Philip Morris International and Altria said on Monday they had entered contract manufacturing arrangements with one another, as ‌Altria looks to grow cigarette imports and exports and take advantage of a tax rebate.

Altria, Philip Morris International sign contract manufacturing deals

Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency

RICHMOND, Va.--(BUSINESS WIRE)--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency.

Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency

Philip Morris gets FDA nod for 11 new nicotine pouches

The U.S. Food and Drug Administration said on Friday it had authorized 11 nicotine pouch products recently launched ‌by Philip Morris , citing lower levels of harmful constituents compared with other oral and smokeless tobacco products.

Philip Morris gets FDA nod for 11 new nicotine pouches

FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI's U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today's action further enhances PMI's leadership role in the smoke-free category. “We are del.

FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review

See News Rankings

Price charts implemented using Lightweight Charts™